What is the category of COVID-19 patients that require plasma therapy? Is there any category of patients who cannot undertake it, because of other health complications?
People who have moderate to severe illness are the right candidates for treatment through plasma therapy. Medically, I would say people who have pneumonia with type I respiratory failure and acute respiratory distress syndrome (ARDS) are the category of patients for this treatment. Patients with mild illness do not require plasma therapy and the treatment is futile in patients with very critical illness with multi-organ failure. There are no other medical conditions under which a patient cannot get this treatment.
How effective is the therapy?
Obviously, it is not a magic bullet and not 100% effective. It is one of the good treatment options available because as of now we do not have any definitive treatment for COVID-19. Most of the therapies are either experimental or have some effectiveness. This is one of the promising therapies, however, it is not an established treatment. More studies are needed to confirm its effectiveness but small studies have merged from the US- they are series of 5-patient report or 10-patient report.
In one series of 5-patient report, all 5 patients on ventilator have successfully come out of it and in another 10 series patients, they found the virus clearing happened rapidly after giving plasma treatment. Therefore, reports like these coupled with our first successful case where the patient responded well to the treatment indicate that plasma therapy is potentially effective therapy. However, larger studies need to be conducted to really say how effective it is.
How is the procedure conducted?
هذه القصة مأخوذة من طبعة May 2020 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة May 2020 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Centre For Sight forms JV with Laxmi Eye Hospital
Expands in Maharashtra; to collaborate with Laxmi Eye Hospital for local market reach.
Diverse information sources are reshaping treatment patterns - Study
A CLIRNET study finds that doctors exposed to multichannel content, demonstrate a 50 percent higher likelihood of diversifying their treatment patterns.
Advanced test for IRD diagnosis launched
Nucleome Informatics unveils an advanced genetic test for diagnosing inherited retinal diseases (IRDS
A device for facial muscle toning, anti-aging. Interested?
Dr Rickson's Dermatherapie Clinic launches device for facial muscle toning, lifting, tightening, and texture improvement.
Therapeutics startup Wundrsight raises $400K in seed round
Wundrsight secures $400,000 in seed round led by Inflection Point Ventures. The fresh funds will be utilized in development of company's VR-based mental health solutions
Odisha's Komal Panda wins James Dyson award
Komal Panda wins the James Dyson Award 2024 for her innovation for diabetes patients, Novocarry, a portable cooling carrier that helps in keeping insulin under desired temperatures.
REHABILITATION SERVICES: AN EVOLVING LANDSCAPE
India's healthcare rehabilitation services market is rapidly evolving, driven by rising demand and investments.
FIVE CYBERKNIFE RADIOSURGERY BENEFITS IN HEAD AND NECK CANCER TREATMENT
Explore why cyberknife radiosurgery promises to be a game-changer in head and neck cancer treatment by revolutionizing care and improving patient outcomes.
CARING FOR THE ELDERLY
India's aging population presents a pressing need for comprehensive healthcare services. Learn how the country's healthcare system can address this challenge.
TACKLING INDIA'S IMMUNIZATION CHALLENGE
India's vast geography and large population challenge comprehensive immunization. Despite successes in children's immunization, more work is needed. A report.